Sort
48,018 grants matching “immunotherapy”
MYCN drives a druggable SUMOylation program in neuroblastoma
$429,802Anthony Charles Faber · Virginia Commonwealth University · R01 · FY2025 · CA
An integrated polymeric carrier for subunit cancer vaccines
$429,683Suzie H Pun · University Of Washington · R01 · FY2021 · CA
A universal multi-drug encapsulation and delivery system employing supramolecular nanogels that self-assemble via dynamic sulfone bonding
$429,643Evan Alexander Scott · Northwestern University · R01 · FY2024 · EB
Project 2: Combined CAR-T cell therapy
$429,640Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Elucidating the role of T-regs in engraftment, GVHD, and DLI immunotherapy
$429,579Christene A Huang · Massachusetts General Hospital · R01 · FY2009 · AI
Antigenic Determinants on HLA-B7 and -A2
$429,529Victor H. Engelhard · University Of Virginia · R01 · FY2009 · CA
Augmenting Antitumor Immunity
$429,477Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2014 · CA
Generation, diversity and homeostasis of T cells subsets throughout the body
$429,476Donna L Farber · Columbia University Health Sciences · P01 · FY2022 · AI
Generation, diversity and homeostasis of T cells subsets throughout the body
$429,476Donna L Farber · Columbia University Health Sciences · P01 · FY2020 · AI
Generation, diversity and homeostasis of T cells subsets throughout the body
$429,476Donna L Farber · Columbia University Health Sciences · P01 · FY2021 · AI
Drug Mechanism of Action-based targeting of tumor subpopulations
$429,473Andrea Califano · Columbia University Health Sciences · U54 · FY2024 · CA
FUNCTIONAL ANALYSIS OF PATHOGENIC AND PROTECTIVE PEANUT ALLERGEN-SPECIFIC HUMAN ANTIBODIES
$429,452Scott Dexter Boyd · Stanford University · R01 · FY2020 · AI
Extracellular vesicle enclosed circular RNA and interferon responses in tumor host interactions.
$429,399Dolores Di Vizio · Cedars-Sinai Medical Center · R21 · FY2025 · CA
Research Training in Blood Diseases and Resources
$429,389Adam Lerner · Boston University Medical Campus · T32 · FY2008 · HL
Cold-responsive gene and drug delivery-potentiated cryoimmunotherapy
$429,350Xiaoming He · Univ Of Maryland, College Park · R01 · FY2024 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$429,318James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
$429,306David B Shackelford · University Of California Los Angeles · R01 · FY2025 · CA
Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
$429,306David B Shackelford · University Of California Los Angeles · R01 · FY2023 · CA
Evaluation of Immune-based Combinations in Metastatic Prostate Cancer
$429,279Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Development of Salmonella vaccines for cancer and viruses
$429,260Olivia Steele-Mortimer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
$429,250Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2019 · AI
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
$429,250Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2018 · AI
Targeted Enzymes for Prodrug Therapy
$429,215University Of Vermont &St Agric College · R01 · FY2005 · CA
Regulation of immune responses by inhibitory receptors
$429,215Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$429,204Fan Pan · Johns Hopkins University · R01 · FY2018 · AI